Related Experiment Video

Updated: Jan 27, 2026

Activating Autophagy by Aerobic Exercise in Mice
08:44

Activating Autophagy by Aerobic Exercise in Mice

Published on: February 3, 2017

12.7K

GCA links TRAF6-ULK1-dependent autophagy activation in resistant chronic myeloid leukemia

Seung Hun Han1, Sovannarith Korm2, Ye Gi Han1

  • 1Department of Biological Sciences, Sungkyunkwan University, Suwon, Republic of Korea.

Autophagy
|April 2, 2019
PubMed

Insights

Grancalcin (GCA) activates autophagy, leading to imatinib resistance in chronic myeloid leukemia (CML). This discovery reveals a new therapeutic target for overcoming resistance to CML treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Biology

Background:

  • Imatinib is a targeted therapy for chronic myeloid leukemia (CML), but resistance remains a significant clinical challenge.
  • The molecular mechanisms underlying imatinib resistance in CML are not fully understood.
  • Identifying novel regulators of resistance is crucial for developing effective CML treatments.

Purpose of the Study:

  • To identify novel molecular regulators of imatinib resistance in chronic myeloid leukemia (CML).
  • To elucidate the role of grancalcin (GCA) in mediating resistance to imatinib therapy.
  • To investigate the involvement of autophagy in GCA-induced imatinib resistance.

Main Methods:

  • Investigated the role of grancalcin (GCA) in imatinib-resistant CML cells.
  • Utilized techniques to analyze autophagy activation and its regulation.
  • Examined the interaction between GCA, TRAF6, and ULK1 in the context of autophagy.

Main Results:

  • Grancalcin (GCA) was identified as a key regulator of imatinib resistance in CML.
  • GCA activates autophagy by promoting the ubiquitylation and stabilization of ULK1 via TRAF6.
  • The GCA-TRAF6-ULK1 axis plays a critical role in mediating resistance to imatinib.
  • This pathway highlights a novel mechanism contributing to CML treatment failure.

Conclusions:

  • Grancalcin (GCA) is a critical mediator of imatinib resistance in CML through the activation of autophagy.
  • The GCA-TRAF6-ULK1 signaling pathway represents a potential therapeutic target for overcoming imatinib resistance.
  • These findings provide a basis for developing novel treatment strategies for CML patients who are resistant to imatinib.
Keywords:
AutophagyTRAF6ULK1chronic myeloid leukemia (CML)grancalcin (GCA)imatinib resistance

More Related Videos

Modeling Chemotherapy Resistant Leukemia In Vitro08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.5K
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.7K

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.7K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
8.9K
X-linked Traits01:19

X-linked Traits

In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
58.3K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
86.4K
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.4K
Resistance01:19

Resistance

When a current moves through any conductor, the conductor causes some level of difficulty for the current to flow. The measure of that difficulty is known as the resistance of the material and is represented by R. Every material has its own resistance. In the case of conductors, heat is emitted whenever a current passes through them. Resistance depends on the resistivity of the material. Resistivity is a characteristic of the material used to fabricate electrical components, whereas the...
5.7K